T1	Participants 63 90	Patients With Heart Failure
T2	Participants 143 233	patients with end-stage heart failure and ongoing symptoms despite optimal medical therapy
T3	Participants 300 385	patients with either ischemic heart failure (IHF) or nonischemic heart failure (NIHF)
T4	Participants 569 615	Sixty patients were stratified by IHF and NIHF
T5	Participants 934 989	All 60 patients were successfully enrolled in the study
T6	Participants 1902 1929	patients with heart failure
